From Medscape Oncology

Medscape Medical News from the

American Society of Hematology (ASH) 56th Annual Meeting

December 06 - 09, 2014; San Francisco, California

Meeting Highlights at a Glance

Top News From ASH 2014: Slideshow Practice-changing studies and exciting preliminary research highlighted this year's meeting in San Francisco.

Conference News

ASH CAR T-cells Are Durable, Drive Pediatric ALL Away
Medscape Medical News, December 18, 2014
ASH An All-Oral Therapy Tested in Multiple Myeloma
Medscape Medical News, December 17, 2014
ASH 87% Complete Remission Rate With Nilotinib in ALL
Medscape Medical News, December 17, 2014
ASH Solutions Needed to Stem Cancer Costs, ASH Experts Say
Medscape Medical News, December 16, 2014
ASH LMWH Best for VTEs in Cancer, But There's a Catch in US
Medscape Medical News, December 16, 2014
ASH No Chemo: Agent Represents a 'New Way of Thinking About AML'
Medscape Medical News, December 16, 2014
ASH ASH Unveils Second Choosing Wisely List
Medscape Medical News, December 15, 2014
ASH New Study on Incidental Pulmonary Embolism and Cancer
Medscape Medical News, December 11, 2014
ASH Novel Agent Reduces Need for Transfusion in MDS
Medscape Medical News, December 11, 2014
ASH Factor XI Inhibitor Cuts VTE Risk in Orthopedic Surgery
Heartwire from Medscape, December 9, 2014
ASH Tailored Treatment Boosts Prognosis in High-Risk T-cell ALL
Medscape Medical News, December 9, 2014

ASH Tangle in AML: Is VALOR 'Crummy' or the 'New Standard'?
Medscape Medical News, December 9, 2014
ASH First Top-flight Evidence of TKI Benefit in AML
Medscape Medical News, December 8, 2014
ASH Treat Young Adults With ALL as Children for Better Outcomes
Medscape Medical News, December 8, 2014
ASH Experimental Antibodies Target Multiple Myeloma
Medscape Medical News, December 8, 2014
ASH Blinatumomab Eradicates Minimal Residual Disease in ALL
Medscape Medical News, December 7, 2014
ASH Practice-Changing Study in HIV-Related Lymphoma
Medscape Medical News, December 7, 2014
ASH First-Time Finding in Posttransplant Hodgkin Lymphoma
Medscape Medical News, December 6, 2014
ASH 'Unprecedented Results' in Relapsed Multiple Myeloma
Medscape Medical News, December 6, 2014
ASH PD-1 Blockade Arrives in Hematologic Cancer
Medscape Medical News, December 6, 2014
ASH What's Hot at 2014 ASH
Medscape Medical News, November 25, 2014

Medscape Oncology© WebMD, LLC

Oncology Insights

The Future of Hodgkin Lymphoma -- Brentuximab and Beyond
Bruce D. Cheson, MD; Ann S. LaCasce, MD, MSc
CLL: It's the Best -- and Most Confusing -- of Times
Bruce D. Cheson, MD; Susan M. O'Brien, MD
Double-Hit Lymphomas Explained, With Surprising EPOCH-R Data
Bruce D. Cheson, MD;
Andrew D. Zelenetz, MD, PhD
R-squared Update: Underwhelms in FL, but Impressive in MCL
Bruce D. Cheson, MD; Nathan H. Fowler, MD
Myeloma Update -- Part 1: Carfilzomib and Panobinostat
Sagar Lonial, MD; Gabriel Miller
Myeloma Update -- Part II: ASPIRE, STRATUS, and New Antibodies
Paul G. Richardson, MD; Gabriel Miller

Pre-Meeting Expert Commentary

ASH 2014: If You're Going to San Francisco...
Bruce D. Cheson, MD

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2018 by WebMD LLC. This website also contains material copyrighted by 3rd parties.